izpis_h1_title_alt

In silico profiling of endocrine-disrupting potential of bisphenol analogues and their halogenated transformation products
ID Nowak, Karolina (Author), ID Jakopin, Žiga (Author)

.pdfPDF - Presentation file, Download (1,32 MB)
MD5: 101F4E8A2749F7BED55A4F9AB1D25346
URLURL - Source URL, Visit https://www.sciencedirect.com/science/article/pii/S027869152300025X This link opens in a new window

Abstract
Due to its endocrine-disrupting properties, bisphenol A (BPA) is being phased out from plastics, thermal paper and epoxy resins, and its replacements are being introduced into the market. Bisphenols are released into the environment, where they can undergo halogenation. Unlike BPA, the endocrine-disrupting potential of BPA analogues and their halogenated transformation products has not been extensively studied. The aim of this study was to evaluate the endocrine-disrupting potential of 18 BPA analogues and their halogenated derivatives by calculating affinities for 14 human nuclear receptors utilizing the Endocrine Disruptome and VirtualToxLab™ in silico tools. Our simulations identified AR, ERs, and GR as the most favorable targets of bisphenols and their derivatives. Several BPA analogues displayed a higher predicted potential for endocrine disruption than BPA. Our models highlighted BPZ and BPPH as the most hazardous in terms of predicted endocrine activities. Halogenation, in general, was predicted to increase the binding affinity of bisphenols for AR, ERβ, MR, GR, PPARγ, and TRβ. Notably, mono- or 2,2′-di-halogenated bisphenols exhibited the highest potential for endocrine disruption. In vitro corroboration of the obtained results should be the next milestone in evaluating the safety of BPA substitutes and their halogenated transformation products.

Language:English
Keywords:BPA, BPA analogues, halogenated bisphenols, nuclear receptors, endocrine disruption, in silico
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
Publication status:Published
Publication version:Version of Record
Year:2023
Number of pages:12 str.
Numbering:Vol. 173, art. 113623
PID:20.500.12556/RUL-148309-8d21348f-c78d-ef65-1ed3-d25bfffe1452 This link opens in a new window
UDC:612.43:620.266.1
ISSN on article:1873-6351
DOI:10.1016/j.fct.2023.113623 This link opens in a new window
COBISS.SI-ID:138155779 This link opens in a new window
Publication date in RUL:11.08.2023
Views:512
Downloads:31
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Food and chemical toxicology
Publisher:Elsevier
ISSN:1873-6351
COBISS.SI-ID:4308780 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:BPA analogi, halogenirani bisfenoli, nuklearni receptorji, endokrine motnje, in silico, endokrinologija

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P1-0420
Name:Napredna imunološka zdravila in celični pristopi v farmaciji

Funder:Other - Other funder or multiple funders
Funding programme:European Federation of Immunological Societies-Immunology Letters, Short-Term Fellowship

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back